Retaglutide is a novel GLP-1 receptor agonist currently under investigation for the management of metabolic disorders. This therapy works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally https://pennysxwu880999.glifeblog.com/37691456/trelaglutide-exploring-a-new-treatment-for-chronic-diseases